China’s humanoid robot IPO slowdown no threat to firms with ‘genuine strength’: Deloitte

Beijing’s recent tightening of approvals for humanoid robot makers seeking initial public offerings (IPOs) poses no threat to companies with clear commercialisation strategies, as funding channels remain wide open for qualified players, according to Deloitte China.

“Market funds are shifting from the ‘blind rush’ of the past to ‘fine screening’,” said Dick Kay, Deloitte China’s capital market services group national leader, at a press conference on Thursday.

Investors and regulators now placed...